Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading
1990

Prognostic Factors in Recurrent Breast Cancer

Sample size: 313 publication Evidence: moderate

Author Information

Author(s): G. Blanco, K. Holli, M. Heikkinen, O.-P. Kallioniemi, P. Taskinen

Primary Institution: Oulu University Central Hospital and Tampere University Hospital, Finland

Hypothesis

What are the prognostic factors that influence the behavior of recurrences in breast cancer?

Conclusion

Histological grading, site of recurrence, and disease-free interval are significant prognostic variables in recurrent breast cancer.

Supporting Evidence

  • Patients with soft tissue recurrences had a median survival of 32 months, while those with visceral recurrences had a median survival of 12 months.
  • ER-positive patients survived longer than ER-negative patients regardless of the site of recurrence.
  • The disease-free interval is significantly related to survival outcomes.

Takeaway

This study looked at breast cancer patients who had recurrences and found that where the cancer comes back and how long the patient was free of cancer before it returned can help predict how well they will do.

Methodology

The study analyzed 613 cases of primary breast cancer with known estrogen and progesterone receptor determinations and complete follow-up.

Limitations

The study excluded bilateral and male breast cancer patients, and the number of cases for some variables was unequal.

Participant Demographics

The study included female patients with histologically verified primary mammary carcinomas.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication